Biogen's market cap is currently $22.13B. The company's EPS TTM is $5.47; its P/E ratio is 14.31; Biogen is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $3.86. See an overview of income statement, balance sheet, and cash flow financials.
